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Background: Worldwide MRSA infections pose life-
threatening problems among critically ill and elderly. In
Belgium the proportion of MRSA/MSSA is 23%, increasing to
35% on Intensive Care Units (ICU). Seen the consequences
on morbidity, mortality and cost anti-nosocomial infection
strategies are implemented. Collecting and analyzing those
data is essential for evaluating and monitoring the situation.
Methods: At admission all patients are systematically
screened by nasal and peri-anal/or groin region. The swabs
are cultured on Chapman medium and consecutively put on
Vitek for antibiotic-susceptibility testing. During hospital-
ization a screening is done two times weekly.
Results: From January 2002 till December 2007, 703
patients were admitted at our ICU and 1494 at our Medium
Care Unit (MCU). Nasal swabs showed to be the best screen-
ing sampling procedure. The mean MRSA positive carriage
at ICU admission is 1.5%. An increased trend was observed
since 2004 (1 to 4%). At the MCU however a remarkably lower
mean admission incidence of 0.5% was observed, with also
the same trend for increase since 2004 (0.1 to 0.5). The
nosocomially acquired MRSA infection rate is 5% on the ICU
and 4% on the MCU. The higher incidence at the ICU admis-
sion is probably due to the fact that this patient population
includes patients who are referred from another ICU, beside
two other risk factors in this population, the age and often
a marginal origin from a social-economic lower class.
Conclusion: We observe a trend for increase the last 3
years which reﬂects the presence of MRSA in the commu-
nity. This increase however is in contrast with the recently
reported decrease of MRSA nosocomial infections in the
global Belgian hospitalization population. Our nosocomial
infection rate stayed at the same level and warrants an
improved infection control in the future Reference: Euro-
pean Antibiotic Resistance Surveillance System (EARSS),
2004.
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Background: Emergence and spread of MDROs are among
the most important global health threats. Surveillance of
these pathogens helps to generate local data, to formu-
late speciﬁc infection control procedures. This study was
conducted to describe risk factors for acquiring MDRO,their
antimicrobial susceptibility pattern, classifying type of ESBL
produced using molecular methods in representative E. coli
and Klebsiella spp.
Methods: Consecutive strains resistant to third genera-
tion cephalosporins from HAI/CAI infection were included
in the study. A proforma was used for risk factor anal-
ysis. Antibiotic susceptibility pattern was determined by
Kirby-Bauer disk diffusion method. In 20 strains phenotypic,
ESBL detection using cefotaxime, ceftazidime with clavu-
lanic acid by double disk synergy test & E-test (AB. Biodisk,
Sweden) was done & genotypic characterisation was done
by PCR for TEM, CTX-M, SHV genes.
Results: Among 254 patients enrolled (91%HAI & 9% CAI)
258 MDRO’S were isolated. Gram-negative bacilli (84%) were
predominant-Enterobacteriaceae (61%) and non - enter-
obacteriaceae (23%) 14.7% of which are pan drug resistant.
No VRE was detected. Diabetes mellitus (43%) was the com-
monest comorbid condition,92 patients had an indwelling
urinary catheter, 80 a central venous catheter, 87 mechan-
ical ventilation, 21 had undergone dialysis. Cefotaxime
clavulanic acid detected 75% of ESBL, Ceftazidime clavu-
lanic acid detected 55%. Among 15 strains detected as ESBL
phenotypically 14 were ESBL genotypically CTX-M is the pre-
dominant 93.3% ESBL genotype. TEM was detected in 80% of
isolates, However no SHV was detected.
Conclusion: HAI account for majority of MDRO,most
Gram-negative Enterobacteriaceae. Majority of ESBL’s were
detected when cefotaxime with clavulanic acid disc than
when ceftazidime clavulanic acid was used. CTX-M is the
predominant genotype. Excessive usage of Cefotaxime in
clinical practice may account for the prevalence CTX-M
genotype.
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